Supplementary Table S3 from AMG 509 (xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate CancerOlivier Nolan-Stevaux, Cong Li,Lingming Liang,Jinghui Zhan, Juan Estrada,Tao Osgood, Fei Li, Hanzhi Zhang,Ryan Case,Christopher M. Murawsky,Bram Estes,Gregory L. Moore,Matthew J. Bernett,Umesh Muchhal,John R. Desjarlais, Binnaz K. Staley,Jennitte Stevens,Keegan S. Cooke,Famke Aeffner, Oliver Thomas,Julia Stieglmaier,Jae-Lyun Lee, Angela Coxon,Julie M. Bailisopenalex（2024）引用 0|浏览4暂无评分关键词Biomarkers for Immunotherapy,Antigen PresentationAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
